Suggested Topics within your search.
Showing 1 - 20 results of 113 for search '"secukinumab"', query time: 0.45s Refine Results
  1. 1
    Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year
    Subjects: “...secukinumab...”
    Get full text
    Article
  2. 2
    Treatment response in patients with moderate-to-severe psoriasis who had inadequate response to prior secukinumab
    by Tai-Siang Chiu, Tsen-Fang Tsai
    Published 2019-01-01
    Subjects: “...secukinumab...”
    Get full text
    Article
  3. 3
    Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic
    by Abhishek De, Sudip Das, Dhiraj Dhoot, Aarti Sarda
    Published 2019-01-01
    Subjects: “...secukinumab...”
    Get full text
    Article
  4. 4
    Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
    by Malakouti M, Jacob SE, Anderson NJ
    Published 2016-10-01
    Subjects: “...secukinumab...”
    Get full text
    Article
  5. 5
    Biologicals in the treatment of psoriasis: The Indian perspective
    by Ajit B Janagond, Aparna Palit
    Published 2017-01-01
    Subjects: “...secukinumab...”
    Get full text
    Article
  6. 6
    Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
    Subjects: “...secukinumab...”
    Get full text
    Article
  7. 7
    Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
    by Kivelevitch D, Amin S, Menter A
    Published 2019-04-01
    Subjects: “...Secukinumab...”
    Get full text
    Article
  8. 8
    THE EVOLUTION OF SPONDYLARTHRITIS – A THERAPEUTIC CHALLENGE
    Subjects: “...secukinumab...”
    Get full text
    Article
  9. 9
    Secukinumab: supervivencia en práctica clínica real
    Subjects: “...Secukinumab...”
    Get full text
    Article
  10. 10
    Experience in using secukinumab in patients with axial psoriatic arthritis
    Subjects: “...secukinumab (cosentyx)...”
    Get full text
    Article
  11. 11
    INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
    by Sh. F. Erdes
    Published 2016-09-01
    Subjects: “...secukinumab...”
    Get full text
    Article
  12. 12
    Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report
    Subjects: “...secukinumab...”
    Get full text
    Article
  13. 13
    Biologics in dermatology: Off-label indications
    Subjects: “...secukinumab...”
    Get full text
    Article
  14. 14
    Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
    Subjects: “...secukinumab...”
    Get full text
    Article
  15. 15
    Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
    Subjects: “...Secukinumab...”
    Get full text
    Article
  16. 16
    Interleukin 17 deficiency and implications in cutaneous and systemic diseases
    Subjects: “...Secukinumab...”
    Get full text
    Article
  17. 17
    Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
    Subjects: “...Secukinumab...”
    Get full text
    Article
  18. 18
    Secukinumab for Psoriasis in Obese Patients: Minireview and Clinical Experience
    Subjects: “...Secukinumab...”
    Get full text
    Article
  19. 19
    Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
    Subjects: “...Secukinumab...”
    Get full text
    Article
  20. 20
    Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
    Subjects: “...secukinumab...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search